C A O'Brian
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- Protein Kinase Regulation and GTPase Signaling
- Receptor Mechanisms and Signaling
- Retinoids in leukemia and cellular processes
- PI3K/AKT/mTOR signaling in cancer
- Cancer therapeutics and mechanisms
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 9
- Cancer therapeutics and mechanisms 3
- Metabolism, Diabetes, and Cancer 2
- Melanoma and MAPK Pathways 2
- Retinoids in leukemia and cellular processes 2
- Oncology 9
- Cancer Treatment and Pharmacology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- I. Bernard Weinstein (4 shared papers)Rob M. J. Liskamp (3 shared papers)Nancy E. Ward (11 shared papers)David H. Solomon (2 shared papers)Gerard M. Housey (4 shared papers)S. Eva Singletary (1 shared paper)I B Weinstein (1 shared paper)Paul T. Kirschmeier (2 shared papers)
- Journals
- Molecular Pharmacology (3 papers)JNCI Journal of the National Cancer Institute (2 papers)Cancer Letters (2 papers)Oncology Reports (2 papers)Scandinavian Journal of Immunology (1 paper)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
C A O'Brian
28 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Oncology 393
- Molecular Biology 952
- Genetics 328
- Toxicology 39
- Pharmacology 88
Countries citing papers authored by C A O'Brian
This map shows the geographic impact of C A O'Brian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C A O'Brian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C A O'Brian more than expected).
Fields of papers citing papers by C A O'Brian
This network shows the impact of papers produced by C A O'Brian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C A O'Brian. The network helps show where C A O'Brian may publish in the future.
Co-authors
The 25 scholars most cited alongside C A O'Brian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of protein kinase C by tamoxifen. | 1985 | 414 |
| 2 | Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. | 1989 | 184 |
| 3 | 1987 | 136 | |
| 4 | 1986 | 125 | |
| 5 | 1988 | 66 | |
| 6 | Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. | 1988 | 64 |
| 7 | 1991 | 45 | |
| 8 | 1992 | 44 | |
| 9 | 1993 | 37 | |
| 10 | 2001 | 34 | |
| 11 | Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes. | 1997 | 28 |
| 12 | 1990 | 28 | |
| 13 | Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin. | 1990 | 28 |
| 14 | 1989 | 27 | |
| 15 | 1990 | 26 | |
| 16 | 1998 | 23 | |
| 17 | Stable expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant phenotype on rat fibroblasts. | 1992 | 23 |
| 18 | 1991 | 20 | |
| 19 | 1989 | 18 | |
| 20 | Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line. | 1994 | 16 |
About C A O'Brian
C A O'Brian is a scholar working on Molecular Biology, Oncology, Pharmacology, Organic Chemistry and Genetics, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (9 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer therapeutics and mechanisms (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Melanoma and MAPK Pathways (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (393 citations), Molecular Biology (952 citations), Genetics (328 citations), Toxicology (39 citations) and Pharmacology (88 citations). C A O'Brian has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include I. Bernard Weinstein, Rob M. J. Liskamp, Nancy E. Ward, David H. Solomon, Gerard M. Housey, S. Eva Singletary, I B Weinstein, Paul T. Kirschmeier, Mark D. Johnson and C D Bucana. Their work appears in journals such as Molecular Pharmacology, JNCI Journal of the National Cancer Institute, Cancer Letters, Oncology Reports and Scandinavian Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.